4,040 research outputs found
Assessment of the Usability and Accuracy of the Simplified One-Diode Models for Photovoltaic Modules
Models for photovoltaic (PV) cells and panels, based on the diode equivalent circuit, have been widely used because they are effective tools for system design. Many authors have presented simplified one-diode models whose three or four parameters are calculated using the data extracted from the datasheets issued by PV panel manufactures and adopting some simplifying hypotheses and numerical solving techniques. Sometimes it may be difficult to make a choice among so many models. To help researchers and designers working in the area of photovoltaic systems in selecting the model that is fit for purpose, a criterion for rating both the usability and accuracy of simplified one-diode models is proposed in this paper. The paper minutely describes the adopted hypotheses, analytical procedures and operative steps to calculate the parameters of the most famous simplified one-diode equivalent circuits. To test the achievable accuracy of the models, a comparison between the characteristics of some commercial PV modules issued by PV panel manufacturers and the calculated current-voltage (I-V) curves, at constant solar irradiance and/or cell temperature, is carried out. The study shows that, even if different usability ratings and accuracies are observed, the simplified one-diode models can be considered very effective tools
The recent change in the italian policies for photovoltaics: Effects on the energy demand coverage of grid-connected pv systems installed in urban contexts
In July 2013, the Italian photovoltaic (PV) support policies changed the feed-in tariff (FIT)
mechanism and turned to a tax credits program, which is currently in force. The aim of this paper is
to investigate how such a radical change has influenced the electricity demand coverage of the PV
systems installed in urban contexts. A methodology, which connects the economic assessment to a
detailed architectural and energy suitability analysis, was applied to some case studies to analyse the
relationships between the physical parameters related to multi-storey buildings (roof shapes, number
of floors and area of flats) and the most relevant economic and financial features affecting the viability
of rooftop PV systems. The study, which considers only the electricity produced by the PV systems
that are economically profitable, highlighted that the tax credits scheme is even more effective in
covering the electrical consumption of densely urbanised Italian city districts. The results, which
are significantly influenced by the latitude of the analysed districts, underline the opportunity for
governments to adopt PV promoting policies that are more sensitive to the amount of solar energy
available in the different regions of their national territory
KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
Malignant gliomas are among the most frequent and aggressive cerebral tumors, characterized by high proliferative and invasive indexes. Standard therapy for patients, after surgery and radiotherapy, consists of temozolomide (TMZ), a methylating agent that blocks tumor cell proliferation. Currently, there are no therapies aimed at reducing tumor cell invasion. Ion channels are candidate molecular targets involved in glioma cell migration and infiltration into the brain parenchyma. In this paper we demonstrate that: i) blockade of the calcium-activated potassium channel KCa3.1 with TRAM-34 has co-adjuvant effects with TMZ, reducing GL261 glioma cell migration, invasion and colony forming activity, increasing apoptosis, and forcing cells to pass the G2/M cell cycle phase, likely through cdc2 de-phosphorylation; ii) KCa3.1 silencing potentiates the inhibitory effect of TMZ on glioma cell viability; iii) the combination of TMZ/TRAM-34 attenuates the toxic effects of glioma conditioned medium on neuronal cultures, through a microglia dependent mechanism since the effect is abolished by clodronate-induced microglia killing; iv) TMZ/TRAM-34 co-treatment increases the number of apoptotic tumor cells, and the mean survival time in a syngeneic mouse glioma model (C57BL6 mice implanted with GL261 cells); v) TMZ/TRAM-34 co-treatment reduces cell viability of GBM cells and cancer stem cells (CSC) freshly isolated from patients.Taken together, these data suggest a new therapeutic approach for malignant glioma, targeting both glioma cell proliferating and migration, and demonstrate that TMZ/TRAM-34 co-treatment affects both glioma cells and infiltrating microglia, resulting in an overall reduction of tumor cell progression
Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals
In cells and tissues resistin affects IL-1β, IL-6, IL-8, IL-12 and TNF-α expression, thus suggesting the existence of a multi-cytokine "resistin pathway". We investigated whether such pathway does exist in humans and, if so, if it is associated with cardiovascular risk factors and with major adverse cardiovascular events (MACE). Serum cytokines were measured in 280 healthy subjects from the Gargano Study 2 (GS2) whose BMI, waist circumference, HOMA IR, triglycerides, HDL-cholesterol, systolic and diastolic blood pressure data were available and in 353 patients with type 2 diabetes and coronary artery disease from the Gargano Heart Study (GHS)-prospective design (follow-up 5.4 ± 2.5 years; 71 MACE). In GS2, cytokines mRNA levels in white blood cells were also measured. In GS2, resistin mRNA was correlated with all cytokines expression (all p < 0.001), but IL-12B. Consistently, serum resistin was correlated with all serum cytokines (all p < 0.001), but IL-12. Expression (eRPS) and serum (sRPS) resistin pathway scores (excluding IL-12) were each other correlated (p < 0.001) and both associated with cardiovascular risk factors (all p < 0.01). In GHS, sRPS was independently associated with MACE (HR = 1.44, 95% CI = 1.10-1.90). Our data indicate the existence of a resistin pathway, which is associated with cardiovascular risk factors and which strongly and independently predicts MACE
The glycoside oleandrin reduces glioma growth with direct and indirect effects on tumor cells
Oleandrin is a glycoside that inhibits the ubiquitous enzyme Na(+)/K(+)-ATPase. In addition to its known effects on cardiac muscle, recent in vitro and in vivo evidence highlighted its potential for anticancer properties. Here, we evaluated for the first time the effect of oleandrin on brain tumors. To this aim, mice were transplanted with human or murine glioma and analyzed for tumor progression upon oleandrin treatment. In both systems, oleandrin impaired glioma development, reduced tumor size, and inhibited cell proliferation. We demonstrated that oleandrin does the following: (1) enhances the brain-derived neurotrophic factor (BDNF) level in the brain; (2) reduces both microglia/macrophage infiltration and CD68 immunoreactivity in the tumor mass; (3) decreases astrogliosis in peritumoral area; and (4) reduces glioma cell infiltration in healthy parenchyma. In BDNF-deficient mice (bdnftm1Jae/J) and in glioma cells silenced for TrkB receptor expression, oleandrin was not effective, indicating a crucial role for BDNF in oleandrin's protective and antitumor functions. In addition, we found that oleandrin increases survival of temozolomide-treated mice. These results encourage the development of oleandrin as possible coadjuvant agent in clinical trials of glioma treatment.SIGNIFICANCE STATEMENT In this work, we paved the road for a new therapeutic approach for the treatment of brain tumors, demonstrating the potential of using the cardioactive glycoside oleandrin as a coadjuvant drug to standard chemotherapeutics such as temozolomide. In murine models of glioma, we demonstrated that oleandrin significantly increased mouse survival and reduced tumor growth both directly on tumor cells and indirectly by promoting an antitumor brain microenvironment with a key protective role played by the neurotrophin brain-derived neurotrophic factor
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
Abstract
Background: Persistent residual viremia (RV) and low grade inflammation and immune activation have been
associated with non-AIDS defining events. The impact of persistent RV and HIV-DNA load on immune activation/
inflammation remains unclear. The purpose of this study was to gain new insights into the relation between
viremia, markers of inflammation and HIV-DNA levels.
Methods: Three hundred and twenty-one HIV-infected patients were studied. A retrospective analysis of viremia
values, prospectively collected for 48 months, was performed. Patients were separated into three groups: 113 TND
(Target Not Detected, patients with sustained undetectable viremia); 113 RV (Residual Viremia, patients who had at
least three detectable viral load (VL) values <37 copies/ml); 95 LLV (Low Level Viremia, patients with at least two VL
values >37 but <200 copies/ml). HIV-DNA, TNF-α, IL-6 and sCD14 were analyzed.
Results: HIV-DNA, sCD14 and TNF-α were significantly lower in the TND group than in the RV and LLV groups. In
addition, RV patients showed lower levels of HIV-DNA and sCD14 than LLV individuals. HIV-DNA load was not
related to markers of inflammation. The ordinal logistic analysis showed that two independent variables were
significantly associated with VL pattern: sCD14, HIV-DNA. In addition NRTIs plus NNRTIs and NRTIs plus PIs were
negatively associated to VL pattern compared to INI-containing regimen.
Conclusions: Persistent undetectable viremia was associated with lower levels of inflammatory markers and HIVDNA.
However, the lack of normalization of these biomarkers in the TND group and the fact that HIV-DNA load was
not associated with inflammation strongly suggest that other mechanisms play a major role in maintaining
inflammation over time
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic hepatitis C virus infection
CD8(+) T cells specific to caspase-cleaved antigens derived from apoptotic T cells represent a principal player in chronic immune activation (CIA). Here, we found that both apoptotic epitope (AE)-specific and hepatitis C virus (HCV)-specific CD8(+) T cells were mostly confined within the effector memory (EM) or terminally differentiated EM CD45RA(+) cell subsets expressing a dysfunctional T-helper-1-like signature program in chronic (c)HCV infection. However, AE-specific CD8(+) T cells produced tumor necrosis factor (TNF)-α and interleukin-2 at the intrahepatic level significantly more than HCV-specific CD8(+) T cells, despite both populations acquiring high levels of programmed death-1 receptor expression. Contextually, only AE-specific CD8(+) T cells correlated with both interferon-stimulated gene levels in T cells and hepatic fibrosis score. Taken together, these data suggest that AE-specific CD8(+) T cells can sustain CIA by their capacity to produce TNF-α and be resistant to inhibitory signals more than HCV-specific CD8(+) T cells in cHCV infection
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial
Objectives
Primary study outcome was absence of treatment failure (virological failure, VF, or treatment interruption) per protocol at week 48.
Methods
Patients on 3-drug ART with stable HIV-1 RNA <50 copies/mL and CCR5-tropic virus were
randomized 1:1 to maraviroc with darunavir/ritonavir qd (study arm) or continue current ART
(continuation arm).Results
In June 2015, 115 patients were evaluable for the primary outcome (56 study, 59 continuation arm). The study was discontinued due to excess of VF in the study arm (7 cases,
12.5%, vs 0 in the continuation arm, p = 0.005). The proportion free of treatment failure was
73.2% in the study and 59.3% in the continuation arm. Two participants in the study and 10
in the continuation arm discontinued therapy due to adverse events (p = 0.030). At VF, no
emergent drug resistance was detected. Co-receptor tropism switched to non-R5 in one
patient. Patients with VF reported lower adherence and had lower plasma drug levels. Femoral bone mineral density was significantly improved in the study arm.
Conclusion
Switching to maraviroc with darunavir/ritonavir qd in virologically suppressed patients was
associated with improved tolerability but was virologically inferior to 3-drug therap
Histological discrimination of fresh and frozen/thawed fish meat: European hake (Merluccius merluccius) as a possible model for white meat fish species
The present study aimed at setting up a standard operating histological procedure to discriminate
fresh from frozen-thawed fish products of the species Merluccius merluccius (European hake). A
preliminary histological analysis of fresh M. merluccius muscle was performed to select the
sampling site and highlight possible time-dependent tissue alterations during shelf-life. To set a
suitable operational grid for discriminating the freezing process, morphological and
morphometrical parameters were assessed on 90 muscle tissue samples collected from 30 fresh, 30
experimentally frozen at -20°31 C and 30 Individual Quick Frozen (IQF) specimens of M.
merluccius. Structural score, presence of freezing vacuoles, a number of vacuoles per field higher
than 1.12 and the presence of interstitial proteinaceous material, which had achieved statistical
significance in group comparisons were chosen as freezing markers. Accuracy and repeatability,
assessed on the analysis of two independent operators (on-training and expert), showed high
analytical specificity and sensitivity and a concordant diagnostic performance regardless the
operators expertise. The grid was finally validated by a single blind test on 30 additional M.
merluccius commercial products and allowed the allocation of all the samples to fresh or frozen
status without inconclusive results. The method could be profitably applied against fraudulent
adulteration practices
- …